This document summarizes a research study that investigated the effect of Fimbristylis ovata, a plant in the sedge family, on vero and MCF-7 cell lines. The study found that a crude methanol extract of F. ovata was able to inhibit the MCF-7 breast cancer cell line with an IC50 value of 73 and the vero cell line with an IC50 value of 280 based on MTT assays. Previous studies had found that F. ovata contains compounds like phenols, saponins, and flavonoids that are known to have anti-cancer effects. The aim of this study was to determine if F. ovata extracts had cytotoxic or anti-cancer potential against these
The use of genetic engineering technology in animals has been associated with ethical issues, some of which relate to animal welfare. Discuss examples of genetically engineering animals and evaluate the ethical concerns of genetic engineering.
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
The use of genetic engineering technology in animals has been associated with ethical issues, some of which relate to animal welfare. Discuss examples of genetically engineering animals and evaluate the ethical concerns of genetic engineering.
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
Compare the use of Lonza KGM Gold Bullet kit and Rheinwald and Green complete FAD medium in primary human epidermal keratinocytes culture and its applicability cells cultured by these medium in the construction of reconstituted skin equivalent model
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...Agriculture Journal IJOEAR
Aim: Breast cancer is the most common cancer in women both in the developed and less developed world. The reported study was designed to explore associations between hMSH2 - Gly322Asp (1032G>A, rs4987188) single nucleotide polymorphism (SNP) and the risk of breast carcinoma in the Polish women.
Material and methods: Blood samples were obtained from women with breast cancer (n=225), treated at the Department of Oncological Surgery and Breast Diseases, Polish Mother’s Memorial Hospital – Research Institute between the years 2005 and 2012. A control group included 220 cancer-free women. Genomic DNA was isolated and the SNP Gly322Asp of hMSH2 was determined by High-Resolution Melter method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele.
Results: This study revealed that single nucleotide polymorphism Gly322Asp of hMSH2 is associated with both breast cancer risk and grading. Moreover, it can be linked with breast carcinoma tumor size and lymph node status. The Asp allele in patients may be a risk factor for breast carcinoma (OR 5.12; 95% CI 3.77 –6.97, p<.0001).
Conclusions: Gly322Asp single nucleotide polymorphism of hMSH2 may be a risk factor of breast cancer in the Polish women.
Growth inhibitory effects of vitamin k2 (menaquinones mk4) on bladder carcin...NAAR Journal
Ubiad1 is a tumor suppressor gene ubiquitously expressed in normal
human tissues and its protein harbors a prenyltransferase functional
domain conserved throughout the evolution. The ability of human
UBIAD1 enzyme to synthesize menaquinone-4 (MK-4) rescues
mitochondrial dysfunction in Drosophila and effectively initiates
apoptosis in various types of tumors through a caspase-dependent
pathway. The objective is to study menaquinone-4-induced apoptosis
signaling pathway and to investigate its anti-tumor activity in human
prostate (PC-3, LNCaP) and bladder (T24, J82) tumor cell lines, an
approach that has not been undertaken yet. Cell viability of cancerous cells
pre-treated with MK-4 showed a significant decrease in dose- and timedependent manner. Moreover, flow cytometry detected apoptotic cells
after treatment with the vitamin. Taken together, these observations
suggest that MK-4 could inhibit cell growth by promoting apoptosis in
prostate and bladder carcinoma cells via different-mediated signal
pathways, making it a potential therapeutic molecule for the prevention
and the cure of cancers.
Medicinal plants and cancer A series of PresentationByMr. Allah Dad Khan ...Mr.Allah Dad Khan
A series of PresentationByMr. Allah Dad Khan Former DG Agriculture Extension KP Province and Visiting Professor the University of Agriculture Peshawar Pakistan allahdad52@gmail.com
ST-001 NanoFenretinide - SciTech Development Lead Drug CompoundSciTech Development
SciTech’s lead compound, ST-001, is a small-molecule immune oncology (IO) nanoFenretinide cancer drug employed as an aqueous nanoparticle suspension for IV administration. The ST-001 nanoFenretinide drug is comprised of the active pharmaceutical ingredient (API) fenretinide in a patented combination with carefully selected phospholipids (inactive ingredients). ST-001 is designed to deliver a 15-fold higher drug to lipid ratio and a >6x concentration of the API than conventional IV formulations achieving therapeutically effective doses without the toxic side effects observed with other delivery systems – a benefit previously unattainable. Recent discovery of the API’s immunotherapeutic effect, in which a reactivated natural immune response compliments the previously understood safe, direct, chemotherapeutic effect (functioning as dual mechanisms of action), has added materially to its value as a versatile therapeutic.
Targeting Telomerase and Topoisomerase-II by Natural Moieties: An Anti-Cancer...CrimsonpublishersCancer
One of the fundamental characteristic of tumor cell is to maintain the telomere length for continues progressive growth and survival. For the same, tumor cell has elevated levels of telomerase enzyme[1]. Telomerase is an unusual enzyme that acts on parts of chromosomes known as telomeres. Telomerase is a ribonucleoprotein and expressed in approximately 85% of different human cancers[2]. There is strong evidence for the existence of an important relationship between telomeres, telomerase and cancer [3]. Normal human cells progressively lose telomeres with each cell division until a few short telomeres become uncapped leading to a growth arrest, known as replicative aging. This phenomenon is totally absent in the cancer and cancer cells are adapted to have higher levels of telomerase enzyme which results in uncontrolled cell division. Attempts have also been made to develop telomere length-and telomerase-based diagnostic tools and anticancer therapeutics [4].
BREAST CANCER DRUG DISCOVERY & RESEARCH FROM VARIOUS WELL KNOWN ETHNOMEDICINAL PLANTS. ESTABLISHED PHYTOMOLECULES WITH CHEMOPREVENTIVE, ANTICANCER ACTIVITIES WITH MINIMAL TOXICITY.
Breast cancer research, in vitro model cell line study, MCF-7 human breast cancer cell line with it's details like history, importance, applications, Culture tips, a model responsible for ER targeted therapy etc.
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
The culture of cells in two dimensions does not reproduce the histological characteristics of a tissue for informative or useful study. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo may be more clinically relevant. Discuss the potential of using three dimensional cell cultures for anti-cancer drug screening.
Compare the use of Lonza KGM Gold Bullet kit and Rheinwald and Green complete FAD medium in primary human epidermal keratinocytes culture and its applicability cells cultured by these medium in the construction of reconstituted skin equivalent model
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...Agriculture Journal IJOEAR
Aim: Breast cancer is the most common cancer in women both in the developed and less developed world. The reported study was designed to explore associations between hMSH2 - Gly322Asp (1032G>A, rs4987188) single nucleotide polymorphism (SNP) and the risk of breast carcinoma in the Polish women.
Material and methods: Blood samples were obtained from women with breast cancer (n=225), treated at the Department of Oncological Surgery and Breast Diseases, Polish Mother’s Memorial Hospital – Research Institute between the years 2005 and 2012. A control group included 220 cancer-free women. Genomic DNA was isolated and the SNP Gly322Asp of hMSH2 was determined by High-Resolution Melter method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele.
Results: This study revealed that single nucleotide polymorphism Gly322Asp of hMSH2 is associated with both breast cancer risk and grading. Moreover, it can be linked with breast carcinoma tumor size and lymph node status. The Asp allele in patients may be a risk factor for breast carcinoma (OR 5.12; 95% CI 3.77 –6.97, p<.0001).
Conclusions: Gly322Asp single nucleotide polymorphism of hMSH2 may be a risk factor of breast cancer in the Polish women.
Growth inhibitory effects of vitamin k2 (menaquinones mk4) on bladder carcin...NAAR Journal
Ubiad1 is a tumor suppressor gene ubiquitously expressed in normal
human tissues and its protein harbors a prenyltransferase functional
domain conserved throughout the evolution. The ability of human
UBIAD1 enzyme to synthesize menaquinone-4 (MK-4) rescues
mitochondrial dysfunction in Drosophila and effectively initiates
apoptosis in various types of tumors through a caspase-dependent
pathway. The objective is to study menaquinone-4-induced apoptosis
signaling pathway and to investigate its anti-tumor activity in human
prostate (PC-3, LNCaP) and bladder (T24, J82) tumor cell lines, an
approach that has not been undertaken yet. Cell viability of cancerous cells
pre-treated with MK-4 showed a significant decrease in dose- and timedependent manner. Moreover, flow cytometry detected apoptotic cells
after treatment with the vitamin. Taken together, these observations
suggest that MK-4 could inhibit cell growth by promoting apoptosis in
prostate and bladder carcinoma cells via different-mediated signal
pathways, making it a potential therapeutic molecule for the prevention
and the cure of cancers.
Medicinal plants and cancer A series of PresentationByMr. Allah Dad Khan ...Mr.Allah Dad Khan
A series of PresentationByMr. Allah Dad Khan Former DG Agriculture Extension KP Province and Visiting Professor the University of Agriculture Peshawar Pakistan allahdad52@gmail.com
ST-001 NanoFenretinide - SciTech Development Lead Drug CompoundSciTech Development
SciTech’s lead compound, ST-001, is a small-molecule immune oncology (IO) nanoFenretinide cancer drug employed as an aqueous nanoparticle suspension for IV administration. The ST-001 nanoFenretinide drug is comprised of the active pharmaceutical ingredient (API) fenretinide in a patented combination with carefully selected phospholipids (inactive ingredients). ST-001 is designed to deliver a 15-fold higher drug to lipid ratio and a >6x concentration of the API than conventional IV formulations achieving therapeutically effective doses without the toxic side effects observed with other delivery systems – a benefit previously unattainable. Recent discovery of the API’s immunotherapeutic effect, in which a reactivated natural immune response compliments the previously understood safe, direct, chemotherapeutic effect (functioning as dual mechanisms of action), has added materially to its value as a versatile therapeutic.
Targeting Telomerase and Topoisomerase-II by Natural Moieties: An Anti-Cancer...CrimsonpublishersCancer
One of the fundamental characteristic of tumor cell is to maintain the telomere length for continues progressive growth and survival. For the same, tumor cell has elevated levels of telomerase enzyme[1]. Telomerase is an unusual enzyme that acts on parts of chromosomes known as telomeres. Telomerase is a ribonucleoprotein and expressed in approximately 85% of different human cancers[2]. There is strong evidence for the existence of an important relationship between telomeres, telomerase and cancer [3]. Normal human cells progressively lose telomeres with each cell division until a few short telomeres become uncapped leading to a growth arrest, known as replicative aging. This phenomenon is totally absent in the cancer and cancer cells are adapted to have higher levels of telomerase enzyme which results in uncontrolled cell division. Attempts have also been made to develop telomere length-and telomerase-based diagnostic tools and anticancer therapeutics [4].
BREAST CANCER DRUG DISCOVERY & RESEARCH FROM VARIOUS WELL KNOWN ETHNOMEDICINAL PLANTS. ESTABLISHED PHYTOMOLECULES WITH CHEMOPREVENTIVE, ANTICANCER ACTIVITIES WITH MINIMAL TOXICITY.
Breast cancer research, in vitro model cell line study, MCF-7 human breast cancer cell line with it's details like history, importance, applications, Culture tips, a model responsible for ER targeted therapy etc.
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
The culture of cells in two dimensions does not reproduce the histological characteristics of a tissue for informative or useful study. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo may be more clinically relevant. Discuss the potential of using three dimensional cell cultures for anti-cancer drug screening.
Artemisinin(qinghaosu), is a drug used for treatment of malaria. It is extracted from the Chinese herb Artemisia annua.
It has three major derivatives— Artemether, Artesunate and Dihydroartemisinin
Neem is a village dispensary free and freely available all over India, with a great fight India could win back its patient from an US company.
If anyone asks me choose a single herb for curing the multiple ailment of mankind NEEM will be first herb of my choice
Prof. Dr Sanjeev Sood
Studies that examined the therapeutic potential of plants leaf extracts
Plant Scientific Name Common Name Type of extraction Proposed active material
1. Solanum viarum Tropical Soda Apple Ether Solasodine glycoalkaloid
2. Acanthus illicifolious Harkucha Kanta Methanol Triterpenoids,Flavonoids,
Alkaloids
3. Annona squamosa Custard Apple Ethyl acetate Acetogenins,Alkaloids,
Dofamine
4 Alstonia scholaris. Chatium Methanol Alkaloids,Flavonoids
5. Calotropis gigantea Akanda Ethanol Triterpenoids,Flavonol
Glycosides
SOCIAL AND ECONOMIC BURDEN OF CANCER ON 2020- REVIEW Tamizhazhagan, Pugazh...Earthjournal Publisher
SOCIAL AND ECONOMIC BURDEN OF CANCER ON 2020- REVIEW
Tamizhazhagan, Pugazhendy, Sakthidasan, Jayanthi, Ki-Hyun Kim
IRO INTERNATIONAL JOURNAL OF MEDICAL AND APPLIED SCIENCES 2018, 1(1):24-30.
Indo-American Journal of Agricultural and Veterinary Sciences .It sounds like the journal you're referring to has a broad scope covering various aspects of Agricultural Sciences and Veterinary Medicine. The topics listed indicate a comprehensive range of fields within these discipline and submitting manuscripts to this journal can explore research and review articles of the journalism research.
The Indo-American Journal of Agricultural and Veterinary Sciences appears to be a scholarly journal focused on publishing research within the fields of agriculture and veterinary sciences of the journals public.
EFFECT OF CITRUS LIMON JUICE AND TAMOXIFEN ON THE OXIDATIVE STRESS ACTIVITIES...oyepata
EFFECT OF CITRUS LIMON JUICE AND TAMOXIFEN ON THE
OXIDATIVE STRESS ACTIVITIES OF MCF-7 CELL INDUCED
BREAST CANCER IN SPRAWGUE DAWLEY RATS. JOSEPH OYEPATA SIMEON
Potential of Natural Compounds in Treating Breast Cancerijtsrd
Breast cancer is the most frequently diagnosed cancer it has been treated for a long time with hormonal, medical assistance, surgery, chemotherapy, and irradiation. Natural compounds obtained for living organisms facilitate caspase mediated cell death and inhibit metastasis, so cancer growth is often prevented with greater efficacy. These compounds are often found to slow the progression of breast cancer. They improved patient survival rates and minimized the number of deaths caused by breast cancer. Apoptosis is defined as the death of cells that occurs as a natural and controlled part of an organisms growth or development. The production of membrane enclosed apoptotic bodies with well preserved organelles, as well as rapid cell condensation and budding. Within the process, there are certain morphological changes. The most important indicator of apoptosis induction is the presence of Cytotoxic anticancer agent. Some plant and natural chemicals promote apoptosis, which obstruct cancer cells through a variety of processes. Komal Kaushik | Gunjan Choudhary | Akanksha | Vandana | Shweta Tyagi | Abhimanyu Kumar Jha "Potential of Natural Compounds in Treating Breast Cancer" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd42410.pdf Paper URL: https://www.ijtsrd.combiological-science/biotechnology/42410/potential-of-natural-compounds-in-treating-breast-cancer/komal-kaushik
International Organization of Scientific Research (IOSR)iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...ijtsrd
Background and objective: Treatment of epithelial ovarian cancer (EOC) is a major challenge with only 30% 5-year survival rate. The outcome of the different therapeutic modalities is still poor, and there is an urgency to find new treatment lines. The effect of mesenchymal stem cells on different tumors is greatly variable. The present work shows the effect of cord blood mesenchymal stem cells conditioned media (MSC CM) in different concentrations on epithelial ovarian cancer stem cells (CD44+ cells) in vitro. Methodology: Ovarian cancer stem cells were subjected to MSC CM of (100%, 75%, 50%, 25%) concentrations for 72 hours followed by investigation of cell morphology, proliferation, apoptosis, cell cycle and expression of certain genes (Oct-4, Sox-2, and Nanog). Results: Cell shrinkage and cell debris was observed with all cancer cell lines by contrast with control. MTT assay showed a reduction in proliferation, in a concentration-dependent manner. The annexin-v results demonstrated a significant early and late apoptosis. There was an increase in the sub-G1 phase of the cell cycles indicating apoptosis. There was a progressive suppression of embryonic stemness genes in all cell lines compared to control. Conclusion: Based on these results, it was concluded that MSC CM may be a potential ovarian cancer inhibitor that may create a new modalities of treatment in ovarian cancer patients. Maher E. Elgaly | Mohamed E. El Ghareeb | Mohamed H. Bedairy | Ahmed M. Badawy | Abeer Shaaban | Farha El shennawy"Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovarian Cancer Cells in Vitro" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-5 , August 2018, URL: http://www.ijtsrd.com/papers/ijtsrd18182.pdf http://www.ijtsrd.com/other-scientific-research-area/other/18182/cord-blood-mesenchymal-stem-cells-conditioned-media-suppress-epithelial-ovarian-cancer-cells-in-vitro/maher-e-elgaly
Gene therapy is a new tool used in combating different diseases. The majority of gene therapy clinical trials are focused on cancer and so it was no coincidence that the first commercial treatment in 2003 was for neoplasia. Currently there are a wide variety of gene therapy proposals involving a large number of anti tumour molecular mechanisms that will conceivably pave the way for highly effective a treatment options. Despite the significant advances that how been made in gene therapy in the fight against cancer, its efficacy,safety and commercial availability are still limited. Ms. Chetana D. Patil | Ms. Siddhi Chavan | Mr. Ritesh Kadam "Gene Therapy for Cancer Treatment" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-5 , August 2019, URL: https://www.ijtsrd.com/papers/ijtsrd26537.pdfPaper URL: https://www.ijtsrd.com/pharmacy/biotechnology-/26537/gene-therapy-for-cancer-treatment/ms-chetana-d-patil
Human health has many aspects, we need to feed the diet which provides better nutrition and gives good health, an absence of disease and good behaviour. There are many health-related problems and conditions are responsible for the weak health and sometimes death causing illness, in which cancer is one most common health risk in human healthcare. Cancer is the state in which cell division is uncontrolled which damage the cells and in the last stage, if incurable caused death. There are many reasons why cell got infected due to cancerous infections, in which food habits and quality of foodstuffs are also increased the risk of cancer, like mycotoxins contamination in the food. MSG additives, taste enhancer, food colouring etc. done by the chemical processing which produces toxins inside the during the oxidation process of food. Cancer is causes of death rate higher than other health risks all over the world. The number of cancer cases is likely to rise up to 24 million by 2035. Several studies were performed in the last years in order to explore and analyze associations between diet and risk of cancer. The risk of cancer is depending on the degree of exposure to contaminated food, availability of nutrients in the body, dietary pattern and lifestyle as well as food behaviour. Research from a number of sources provides information that some vegetables, fruits, and whole grains, dietary fibre, certain micronutrients, few fatty acids and physical activity protect against cancers. Whereas poor dietary intake, imbalanced nutrition, less physical activity trances fatty acids, food processing and cooking method may increase risks.
Keywords: Cancer, death, nutrition, fruits and vegetable
As the conventional therapeutic strategies fail to fulfil the major requirements for a successful cancer therapy. The use of naturally developed anticancer agents has evolved as an alternative safe, low-cost and convenient one.
A Comprehensive Review on Anticancer activity of Different Plant Species
my article
1. Available online www.jocpr.com
Journal of Chemical and Pharmaceutical Research, 2015, 7(9):284-290
Research Article
ISSN : 0975-7384
CODEN(USA) : JCPRC5
284
Effect of Fimbristylis ovata (Burm. F) J. Kern on vero cell and
MCF-7 cell morphology
Sowmya Thomas and E. Joyce Sudandara Priya*
Department of Botany, Madras Christian College (Autonomous), Tambaram East, Chennai, Tamil Nadu, India
_____________________________________________________________________________________________
ABSTRACT
Breast cancer is a complex genetic disease that is caused in about 80% of the women due to various environmental
factors. The allopathic treatments which cause side effects are not appreciated in the recent years. Hence there has
been a long-standing interest to find anticancer agents present in plants to eliminate side effects. Fimbristylis ovata
(Burm.f.)Kern which is being used traditionally for the treatment of wounds and other associated diseases which
could lead to malignancy. Since there has been no scientific data on the effect of Fimbristylis ovata on Vero cell line
and MCF-7 cell line the concept of investigating its cytotoxic and anticancer potential was brought up. The tests
were evaluated using MTT assay and it was noted that the crude methanol extract of Fimbristylis ovata could inhibit
MCF-7 cell line at an IC50 value of 73 and Vero cell line at an IC50 value of 280.
Key words: Fimbristylis ovata, Vero Cell line, MCF-7 cell line, anticancer, methanolic extract.
_____________________________________________________________________________________________
INTRODUCTION
Cancer is a potentially fatal disease caused by environmental factors that mutate gene encoding critical cell –
regulatory proteins. The resultant aberrant cell behavior leads to expansive masses of abnormal cells that destroy
surrounding normal tissues and can spread to the vital organs resulting in disseminated disease, commonly a
harbinger of imminent patient death [1]. Cancer begins with mutations in DNA, which instructs the cells, how to
grow and divide. Normal cells have the ability to repair most of the mutations in their DNA, but the mutations which
is not repaired and causing the cell to grow becomes cancerous [2]
Breast cancer is the most common cancer and the most frequent cause of death in women [3]. Breast cancer is the
second most common cancer among the women in India, after cancer of the cervix uteri. Locally advanced breast
cancer constitutes more than 50% to 70% of patients presenting for treatment [4].
Breast cancer is caused by repeated exposure of breast cells to circulating ovarian hormones [5]. Clinical, animal
and epidemiological studies have clearly demonstrated that breast cancer is a hormonally mediated disease and
several factors that influence hormonal status or are markers of change in hormonal status have been shown to be
associated with the risk of breast cancer [6]; [7];[8] A variety of constitutional risk factors have been reported such
as multipolarity, early onset of menarche, delayed first birth, late menopause and decreased parity. These risk factors
point toward endogenous estrogens as likely players in the initiation, progression and promotion of breast cancer [9].
Chemotherapy, being a major treatment modality used for the control of advanced stages of malignancies and as a
prophylactic against possible metastasis, exhibits severe toxicity on normal tissues [10]; [11]. Today despite
2. Sowmya Thomas and E. Joyce Sudandara Priya J. Chem. Pharm. Res., 2015, 7(9):284-290
______________________________________________________________________________
285
considerable efforts, cancer still remains an aggressive killer worldwide. Moreover, during the last decade, novel
synthetic chemotherapeutic agents currently in use clinically have not succeeded in fulfilling expectations despite
the considerable cost of their development. Therefore there is a constant demand to develop new effective and
affordable anticancer drugs [12]. The search is goal – oriented. The goal is to find new active molecules in plants,
with the ability to stop and prevent growth of cancer cells.[13].
Natural products (specifically plants) have received increasing attentions over the past years for their potential as
novel cancer preventive and therapeutic agents [14][15]. The plant derived compounds are inhibitor of various
stages of tumourogenisis and associated inflammatory processes, underlying the importance of these products in
cancer prevention and therapy [12]. It is well established that there is a long history of the use of different medicinal
plants and natural products as anticancer agents in many parts of the world. A variety of medicinal plants have been
useful sources of clinically relevant antitumor compounds [16] In addition, it is reported that 50% of drugs in
clinical trial for anticancer activity were from natural sources or are related to them [17]. Thus, much research
accomplished today focuses on the investigation of antitumor activity of medicinal plants and the development of
new drugs to treat cancers as well as other incurable diseases [18]; [19]; [20]. Although plants have the potential to
synthesize extremely complex molecular structure extensive screening procedures are required to identify, isolate
and purify these compounds. Examples of plant-derived compounds with anticancer activity used clinically include:
the Vincaalkaloids (which induce metaphase arrest by interfering with microtubule assembly) vinblastine, vincristine
and vincamine derived from Vincarosea, and their synthetic derivatesvindesine and vinorelbine; the topoisomerase
inhibitors campothecin, an alkaloid isolated from Campothecaaccuminata, and etoposide, a semi-synthetic
derivative of podophyllotoxin, an antineoplastic glucoside obtained from Podophyllumpeltatum; the taxoids
paclitaxel (taxol) and the synthetic analogue docetaxel (taxotere), which stabilize microtubules and disrupt mitosis.
The various compounds described above are associated primarily with the treatment of breast cancer. [13]
Many natural dietary agents, including vegetables, fruits, herbs, and spices have been used in traditional medicines,
as non-conventional treatments, for thousands of years, but without sufficient proofs. Effectiveness of such natural
dietary agents might lead to the development of natural and novel drugs with low or no side effects.
The genus FimbristylisVahl., belongs to the family Cyperaceae of Monocotyledons. There are about 250 genera
commonly grown in warm climatic condition. Most of the species belonging to this genus are grown as weeds. The
plant is found distributed in Asian continents, Africa, Australia and in other tropics and subtropics and warm
temperate regions. It has a wide range of medicinal properties.
The species Fimbristylis ovata (Burm.f.)Kern.is a perennial sedge, widely distributed in tropics and subtropics and
low lying grasslands. It is often found in marshes and in seasonally inundated areas at the edges of pools, lake sides
and ditches. [21]. Fimbristylis ovata (Burm.f.) Kern., known by its common name flat spike sedge or “Ya-sae-ma”
in Thai, belongs to the family Cyperaceae[22]
Fimbristylis ovata has been long used for treating adenitis, scrofula, syphilis, cough, bronchitis, and asthma [23];
[24]Fimbristylis ovata has antioxidant activity and inhibits RAGE gene expression in a human lung adenocarcinoma
epithelial cell line. [25]
The methanolic extracts of Fimbristylisovata leaves revealed the presence of tannins, saponins, flavonoids,
anthocyanins, β-cyanins, quinines, cardiac glycosides, phenols and coumarins. [26]. But the underlying mechanism
of its therapeutic activity is unknown. Among the biochemical compounds that are mentioned above few of the
compounds such as phenols, saponins, coumarins and flavonoids (Silymarin) are effective against human breast
cancer. The aim of this study was to investigate the effects of Fimbristylis ovata extracts on Human Breast Cancer
(MCF-7) cell lines.
Plants in the family Cyperaceae consist of several components such as phenolic compounds, flavonoids, alkaloid,
glycoside proteins, amino acids, tannins, and saponins.[27]
As presented above, some researches have shown that certain constituents of the Fimbristylis ovata and its ethanolic
extracts of the plant are effective against RAGE genes [25]. But to our knowledge, no studies exist on the effects of
the methanolic extract of Fimbristylis ovata against the proliferation of breast cancer cells. Therefore, the potential
3. Sowmya Thomas and E. Joyce Sudandara Priya J. Chem. Pharm. Res., 2015, 7(9):284-290
______________________________________________________________________________
286
of Fimbristylis ovata to induce death of human breast cancer cells has been investigated here in the hope of finding a
natural treatment.
EXPERIMENTAL SECTION
Cell lines:-
The human breast cancer cell line MCF-7 (Michigan Cancer Foundation-7) (King Institute, Chennai), is an epithelial
invasive breast ducal carcinoma cell line, which is estrogen and progesterone receptor positive. Vero cell lines
which were acquired from the kidney epithelial cells extracted from African Green Monkey.
Both MCF-7 and Vero cell lines were cultivated in Dulbecco’s Minimal Essential Medium (DMEM) supplemented
with 10% fetal calf serum (FCS) and stored in the incubator provided with 5% CO2 atmosphere at 37ºC, and 96%
relative humidity.
Determination Of Cell’s Morphology Using Inverted Light Microscopy:-
The Vero and MCF-7 cell lines were suspended in DMEM containing 10% FBS and kept for incubation and
subcultured several times. The degree of subculturing a cell line has undergone, is often expressed as “passage
number”, which can generally be thought of as the number of times cells have been transferred from vessel to vessel.
Cell lines at high passage numbers experience alteration in morphology, response to stimuli, growth rates, and
protein expression and transfection efficiency, compared to lower passage cells. After several passage the cell lines
ready for the test is stored in the incubator provided with 5% CO2 atmosphere at 37ºC, and 96% relative humidity.
The growth of the cells was monitored every 24 hours for 3 days under inverted microscope. The medium was then
discarded and the cells were split and transferred into new medium. To determine the effects of Fimbristylis ovata
whole plant crude methanol extract on the morphology of the cells, both MCF-7 and Vero cell lines
The whole plant ofFimbristylis ovata was obtained locally and they were cleaned, shade dried and powdered using
an electric grinder. The extract was prepared viasoxhlet apparatus. For the cell line studies 10 mg of Fimbristylis
ovata crude methanol extract was weighed and dissolved in 25 µl of DMSO without FCS in MEM media. Several
dilutions of the extract in serum-free medium were prepared [extract:SFM (vol/vol); (5µl of extract in 1000µl of
SFM ), 10µ l, 25µ l, 50µl, 75µl, 100µl, 200µl, 300µl, 400 µl, 500 µl and 600 µl for Vero cell lines and till 300 µl for
MCF-7 and were stored at -80ºC.
Effect Of Methanol Extract Of The Plant On The Cell Lines:-
The 96 well plates seeded with Vero &MCF-7 cell lines were taken out of the incubator and brought to the laminar
air flow. The medium in the 96 well plates were discarded. The cells adherent to the surface was left undisturbed.
These cells were treated with extract stock solution with each concentration of the extract in each well. The plates
were then incubated in 5% CO2 atmosphere, at 37ºC, and 96% relative humidity. The treated cell lines were
monitored for 3 days at an interval of 24 hours.
MTT assay:-
After 72 hours, the medium was aspirated carefully and discarded. 50 µl of MTT solution added was to each well.
The plate was incubated for 4 hours at 37ºC in an incubator with 5% CO2 to allow intracellular reduction of the
soluble yellow MTT to the insoluble purple formazan crystals. The supernatant was removed, 50 µl of propanol was
added, and the plates were gently shaken to solubilize the formed formazan. The suspension was transferred to a
spectrophotometer cuvette and absorbance values were read at 570 nm using DMSO as blank.
RESULTS AND DICUSSION
Fimbristylis ovata belonging to Cyperaceae used by the African tribe for wound healing and other ailments were
selected to study its activity against breast cancer. The crude extract of this plant was selected to test the anticancer
activity based on the chemical constituents such as tannins, saponins, flavonoids, cardiac glycosides, phenols and
coumarins which have been reported in Fimbristylisovata (Sowmya Thomas and ShyamaMukundan, 2012). A crude
methanol extract was prepared by Soxhlet extraction method and its potential to treat cancer was assessed by
performing an MTT assay on breast cancer cell lines MCF-7. This was done by monitoring the viability of the
human breast cancer cell line treated with the methanol crude extract of the plant for every 24 hours for 3 days. To
prove it better a MTT assay was tested on Vero cell lines which are normal cell lines obtained from kidney epithelial
4. Sowmya Thomas and E. Joyce Sudandara Priya J. Chem. Pharm. Res., 2015, 7(9):284-290
______________________________________________________________________________
287
cells of African green monkey. Both the cell lines were stored, maintained and passaged frequently in King Institute,
Chennai, India.
GRAPH - 1
..
GRAPH - 2
..
The result of the cytotoxicity and antiproliferative activity of the methanolic extract are photographed and scanned
in the Figure 1 and 2 respectively. The plant extract (10mg/ml) started to lyse the Vero cell lines at higher with the
IC50 value 280 whereas the extract inhibited the proliferation of MCF-7 at an IC50 value of 73. The efficacy of cell
0
20
40
60
80
100
120
5 10 25 50 75 100 200 300 400 500 600
%ofToxicityofcrudeextract
Concentration of crude extract
CYTOTOXIC ACTIVITY OF THE METHANOL CRUDE EXTRACT OF
Fimbristylis ovata AGAINST VERO CELL LINES
% OF TOXICITY
0
20
40
60
80
100
120
5 10 25 50 75 100 200
%ofthetoxicitycrudeextract
Concentration of the crude extract
CYTOTOXIC ACTIVITY OF THE METHANOL CRUDE EXTRACT OF Fimbristylis ovata AGAINST
MCF-7 CELL LINES
% OF TOXICITY
5. Sowmya Thomas and E. Joyce Sudandara Priya J. Chem. Pharm. Res., 2015, 7(9):284-290
______________________________________________________________________________
288
death varied depending upon the concentration of the extract which was serially diluted as 5, 10, 25, 50, 75, 100,
200, 300 µl/ml. The IC50 value which was obtained by plotting a graph indicated the apt concentration to inhibit the
proliferation which is depicted in graph 1 and 2 respectively.
FIGURE - 1
FIGURE - 2
6. Sowmya Thomas and E. Joyce Sudandara Priya J. Chem. Pharm. Res., 2015, 7(9):284-290
______________________________________________________________________________
289
The MCF-7 cell treated with DMSO retains its normal angular or polygonal shape. Most cells have intact and large
vesicular nuclei with prominent nucleoli. The treated MCF-7 cells with 50% extract showed a significant loss of cell
processes and marked changes in morphology such as shrinkage and irregular shape.
Since, no studies exist on the possible mechanism of the therapeutic effect of Fimbristylisovata the potential of the
methanolic extract of the whole plant was investigated to find a natural remedy against breast cancer. Previous
studies have cited the anti-cancer property of phytochemicals such as tannins, saponins, flavonoids, cardiac
glycosides, phenols and coumarins which have been reported inFimbristylisovata (Sowmya Thomas and
ShyamaMukundan, 2012). Therefore, the anti-cancer activity observed in crude methanol extract of this plant
Fimbristylis ovata may be due to phytochemical constituents or due to any single chemical compound. According to
the results obtained, Fimbristylis ovata appeared to be a potent anti-cancer agent and to the best of our knowledge
this is the first report on anti-cancer activity of Fimbristylis ovata against MCF-7 cell line.
CONCLUSION
The IC50 value of the crude extract on MCF-7 cell lines was lower compared to the IC50 value of the crude extract
treated on Vero cell lines. This indicates that the crude methanol extract is more effective on human breast cancer
cell line than on the normal cell lines. With these results it is ascertained that a major bioactive compound present in
the crude extract has a high anti proliferative activity which can be isolated by one of the recent chromatographic
techniques.
Acknowledgement
The authors are thankful to Mr. Ferroz Ahmed, King Institute, Porur, Chennai for providing infrastructural facilities,
support and guidance throughout this work.
REFERENCES
[1] Alison R Malcolm. Encyclopedia of Life Sciences.,2001, 1-9.
[2] Prakash Om; Kumar Amit; Kumar Pawan; Ajeet.American journal of Pharmacological Sciences.,2013 Vol.1,
No.6, 104-115.
[3] KawalecPawel, LopuchSylwia, MikrutAlicja. Clinical Breast Cancer.,2014,Volume 15, Issue 2, pp 90-100.
[4] Chopra Rakesh. Journal of Clinical Oncology., 2001, 19(18 Suppl); 106S-111S.
[5] MM Henderson. Cancer., 1995,76; 2053-8.
[6] A Schatzkin, DY Jones, RN Hoover, PRTaylor, LA Brinton, RG Ziegler. N Engl J Med., 1987;316:1169-73.
[7] GR Howe, T Hirohata, TG Hislop, JMIscovich, JM Yuan, K Katsouyanni. J Natl Cancer Inst., 1990, 82:561-9.
[8] YT Gao, XO Shu, Q Dai, JD Potter, LA Brinton, W Wen. Int. J. Cancer., 2000, 87, 295-300.
[9] AS Bhadoria, U Kapil, N Sareen. P Singh.A case-control study in tertiary care hostpital of North India., 2015.
[10] A. P. Somkumar. Study on anticancer effects of Ocimum sanctum and Withaniasomnifera on experimentally
induced cancer in mice, PhD thesis. JNKVV Jabalpur., 2003.
[11] S. Madhuri; G. Pandey.Indian drugs, 2006.43, 869-74.
[12] Elisha Solowey, Michal Lichtenstein, Sarah Sallon, Helena Paavilainen, Elaine Solowey, and Haya Lorboum-
Galski. The Scientific World Journal., 2014 Article ID 721402, 12 pages
[13] ZoharaYanivBachrach. Scientific Journal of the Faculty of Medicine in Nis.,2012. 29(3) : 117-123.
[14] D. J. Newman. Journal of Medicinal Chemistry,. 2008 vol. 51, no. 9, pp. 2589-2599.
[15] D. J. Newman, G. M.Cragg, and K. M. Sande. Journal of Natural Products.,2003. vol. 66, no. 7, pp. 1022-
1037.
[16] GM Cragg, MR Boyd, JH Cardellina, DJ Newman, KM Snader, TG McCloud. DJ Chadwick, J Marsh
(Eds.).,1994. pp. 178–196.
[17] GM Cragg, DJ Newman. ExpOpin Invest Drugs.,2000, 9: 1–15.
[18] A Kamuhabwa, C Nshimo, P. J de Witte Ethnopharmacol.,2000 70: 143–149
[19] EA Goun, VM Petrichenko, SU Solodnikov, TV Suhinina, MA Kline, G Cunningham, C Nguyen, H Miles. J
Ethnopharmacol.,200281: 337–342.
[20] LV Costa-Lotufo, MTH Khanb, A Ather, DV Wilke, PC Jimenez, C Pessoa, MEA de Moraes, MO de Moraes
J.Ethnopharmacol., 2005 99: 21–30.
[21] IUCN Cook 1995.
7. Sowmya Thomas and E. Joyce Sudandara Priya J. Chem. Pharm. Res., 2015, 7(9):284-290
______________________________________________________________________________
290
[22] DA Simpson and T Koyama Flora of Thailand Volume 6 Part 4: Cyperaceae. (Santisuk T and Larsen K, eds).
Royal Forest Department, Bankok., 1998.
[23] HM Burkill, and J Hutchinson. The Useful Plants of West Tropical Africa. 2nd
ed. Kew: Royal Botanic Garden,
London., 1985
[24] C.P.Khare. Springer, Berlin, 2007; 269.
[25] SupornSukjamnong and RachanaSantiyanont. Journal of Chemical and Pharcaceutical Research.,20124(5):
2483-2489
[26] Sowmya Thomas and ShyamaMukundan. International Journal of Pharmaceutical Research and Development
(IJPRD).,2012
[27] NC Chaulya, PK Haldar and A J Mukherjee. Pharmacogn. Phytochem., 2010, 2:40-43